» Articles » PMID: 39204089

Emerging Roles of Natural Compounds in Osteoporosis: Regulation, Molecular Mechanisms and Bone Regeneration

Overview
Publisher MDPI
Specialty Chemistry
Date 2024 Aug 29
PMID 39204089
Authors
Affiliations
Soon will be listed here.
Abstract

Bone health is a critical aspect of overall well-being, and disorders such as osteoporosis pose significant challenges worldwide. East Asian Herbal Medicine (EAHM), with its rich history and holistic approach, offers promising avenues for enhancing bone regeneration. In this critical review article, we analyze the intricate mechanisms through which EAHM compounds modulate bone health. We explore the interplay between osteogenesis and osteoclastogenesis, dissect signaling pathways crucial for bone remodeling and highlight EAHM anti-inflammatory effects within the bone microenvironment. Additionally, we emphasize the promotion of osteoblast viability and regulation of bone turnover markers by EAHM compounds. Epigenetic modifications emerge as a fascinating frontier where EAHM influences DNA methylation and histone modifications to orchestrate bone regeneration. Furthermore, we highlight EAHM effects on osteocytes, mesenchymal stem cells and immune cells, unraveling the holistic impact in bone tissue. Finally, we discuss future directions, including personalized medicine, combinatorial approaches with modern therapies and the integration of EAHM into evidence-based practice.

Citing Articles

Hypoxia Promotes Osteoclast Differentiation by Weakening USP18-Mediated Suppression on the NF-κB Signaling Pathway.

Fan X, Li B, Chai S, Zhang R, Cai C, Ge R Int J Mol Sci. 2025; 26(1.

PMID: 39795869 PMC: 11719700. DOI: 10.3390/ijms26010010.


Mechanistic Exploration of Roxb. in Osteoarthritis: Insights from Network Pharmacology, Molecular Docking, and In Vitro Validation.

Ilyas S, Baek C, Manan A, Choi Y, Jo H, Lee D Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458926 PMC: 11510151. DOI: 10.3390/ph17101285.

References
1.
Tabatabaei-Malazy O, Salari P, Khashayar P, Larijani B . New horizons in treatment of osteoporosis. Daru. 2017; 25(1):2. PMC: 5297185. DOI: 10.1186/s40199-017-0167-z. View

2.
Izawa A, Ishihara Y, Mizutani H, Kobayashi S, Goto H, Okabe E . Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice. Infect Immun. 2014; 82(5):1904-13. PMC: 3993437. DOI: 10.1128/IAI.01618-13. View

3.
Cheng L, Jin X, Shen H, Chen X, Chen J, Xu B . Icariin attenuates thioacetamide‑induced bone loss via the RANKL‑p38/ERK‑NFAT signaling pathway. Mol Med Rep. 2022; 25(4). PMC: 8864607. DOI: 10.3892/mmr.2022.12642. View

4.
Tian H, Jiang T, Yang K, Ning R, Wang T, Zhou Q . α-Asarone Attenuates Osteoclastogenesis and Prevents Against Oestrogen-Deficiency Induced Osteoporosis. Front Pharmacol. 2022; 13:780590. PMC: 8971932. DOI: 10.3389/fphar.2022.780590. View

5.
Liu T, Yao M, Zhao Y, Zhao S, Rui C, Yang F . Chinese medicine Gushukang capsule for treating primary osteoporosis: a systematic review and meta-analysis. J Orthop Surg Res. 2023; 18(1):845. PMC: 10631217. DOI: 10.1186/s13018-023-04264-9. View